Publication:
PDCD1 polymorphisms are not associated with Takayasu's arteritis in Turkey

dc.contributor.authorsDireskeneli, H.; Tuna-Erdogan, E.; Gunduz, F.; Bandurska-Luque, A.; Alparslan, B.; Kebe, M.; Uyar, F. A.; Bicakcigil, M.; Aksu, K.; Kamali, S.; Ozbalkan, Z.; Ates, A.; Karadag, O.; Ozer, H. T. E.; Akar, S.; Onen, F.; Seyahi, E.; Onat, A. M.; Aydin, S. Z.; Yilmaz, N.; Cefle, A.; Cobankara, V.; Tunc, E.; Ozturk, M. A.; Fresko, I.; Karaaslan, Y.; Akkoc, N.; Yucel, A. E.; Kiraz, S.; Keser, G.; Inanc, M.; Saruhan-Direskeneli, G.
dc.date.accessioned2022-03-12T18:07:41Z
dc.date.accessioned2026-01-10T18:33:37Z
dc.date.available2022-03-12T18:07:41Z
dc.date.issued2012
dc.description.abstractObjectives. Takayasu's arteritis (TA) is a chronic arterial inflammation of unknown etiology involving mainly the aorta and its major branches. Based on the associations of programmed death-1 (PD-1) protein encoding gene (PDCD1) with connective tissue diseases and vasculitides, PDCD1 polymorphisms are studied for susceptibility to TA in this study. Methods. The study group is made up of TA patients (n=229) fulfilling the 1990 ACR classification criteria and compared to 193 healthy controls (HC). PD-1.3, PD-1.5 and PD-1.6 single nucleotide polymorphisms of PDCD1 gene are genotyped by polymerase chain reaction and restriction analysis (PCR-RFLP). Results. The distribution of PD-1.5 polymorphism in TA patients and HC revealed a similar presence of TT genotype in patients and controls (13.3% vs. 11.4%). PD-1.3 and PD-1.6 were less polymorphic and did not differ between the groups. Rare AA genotype of PD-1.3 (1.4% vs. 1.0%) and AG genotype of PD-1.6 was again similarly (22.4% vs. 19.2%) present in TA and HC. Conclusion. PD-1.3, 1.5 and 1.6 polymorphisms of PDCD1 gene, which were shown to be associated with various autoimmune disorders and vasculitides, are not associated with a susceptibility to TA in Turkish population.
dc.identifier.doidoiWOS:000304499000005
dc.identifier.eissn1593-098X
dc.identifier.issn0392-856X
dc.identifier.pubmed22274654
dc.identifier.urihttps://hdl.handle.net/11424/231047
dc.identifier.wosWOS:000304499000005
dc.language.isoeng
dc.publisherCLINICAL & EXPER RHEUMATOLOGY
dc.relation.ispartofCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectTakayasu's arteritis
dc.subjectPDCD1
dc.subjectprogrammed cell death
dc.subjectRHEUMATOID-ARTHRITIS
dc.subjectGENE POLYMORPHISM
dc.subjectANKYLOSING-SPONDYLITIS
dc.subjectSUSCEPTIBILITY
dc.subjectCELLS
dc.subjectPD-1
dc.subjectEXPRESSION
dc.subjectDISEASE
dc.subjectALLELE
dc.subjectTISSUE
dc.titlePDCD1 polymorphisms are not associated with Takayasu's arteritis in Turkey
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPageS14
oaire.citation.issue1
oaire.citation.startPageS11
oaire.citation.titleCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
oaire.citation.volume30

Files